PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, July 13, 2009: FLML, ATEC, MENT, SPSS, BMRN and MPET.

-- July 10, 2009 Flamel Technologies, SA (NASDAQ: FLML | Quote | Chart | News | PowerRating) closed at $8.03 on a volume of 44,767 shares.

In a press release out on July 13, 2009 Baxter and Flamel Technologies Announce Collaboration to Formulate Longer Acting Forms of Blood Clotting Factors

DEERFIELD, Ill. & LYON, France, Jul 13, 2009 -- Baxter International Inc. (NYSE: BAX) and Flamel Technologies, SA (NASDAQ: FLML | Quote | Chart | News | PowerRating) announced today that they have entered into agreement to formulate controlled release applications of blood clotting factor replacement therapies using Flamel's Medusa(R) Technology. The work between the two companies will focus on developing longer-acting formulations with the objective of reducing the frequency of infusions required to treat blood clotting disorders in hemophilia. Pursuant to the agreement between the two companies, Flamel will receive technology access fees totaling EUR 2.5 million. Baxter will pay all development costs for the program and have an exclusive right to negotiate a license to the Medusa platform.

About Flamel Technologies

Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications. Flamel's Medusa technology is designed to deliver controlled-release formulations of therapeutic proteins and peptides and other molecules, without reduction in bioactivity. Micropump(R) is a controlled release and taste-masking technology for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for COREG CR(R).

-- July 10, 2009 Alphatec Holdings, Inc. (Nasdaq:ATEC) closed at $2.97 on a volume of 37,992 shares

In a press release on july 13, 2009 Alphatec Spine to Hold 2Q 2009 Financial Results Investor Call

CARLSBAD, Calif., Jul 13, 2009 -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a leading medical technology company involved in the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders, with a focus on treating conditions affecting the aging spine, announced today that it will hold an investor call on Monday, August 3, 2009 to discuss the Company's second quarter 2009 financial results.

About Alphatec Spine

Alphatec Spine, Inc. is a wholly owned subsidiary of Alphatec Holdings, Inc. (Nasdaq:ATEC). Alphatec Spine is a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, primarily focused on the aging spine. The Company's mission is to combine world-class customer service with innovative, surgeon-driven design that will help improve the aging patient's quality of life. The Company is poised to achieve its goal through new solutions for patients with osteoporosis, stenosis and other aging spine deformities, improved minimally invasive products and techniques and integrated biologics solutions. In addition to its U.S. operations, The Company also markets its spine products in Europe. In Asia, the Company markets a broad line of spine and orthopedic products through its subsidiary, Alphatec Pacific, Inc. For more information, please visitwww.alphatecspine.com.

-- July 10, 2009 Mentor Graphics Corporation (NASDAQ:MENT) closed at $6.04 on a volume of 623,640 shares.

In a press release out on July 13, 2009 Mentor Graphics Chairman and CEO to Present Keynote at Semicon West

WILSONVILLE, Ore., Jul 13, 2009 -- Mentor Graphics Corporation (NASDAQ:MENT) today announced that Dr. Walden C. Rhines, Chairman and CEO, will present the following keynote at Semicon West 2009 in San Francisco, CA.

About Mentor Graphics

Mentor Graphics Corporation (NASDAQ:MENT) is a world leader in electronic hardware and software design solutions, providing products, consulting services and award-winning support for the world's most successful electronics and semiconductor companies. Established in 1981, the company reported revenues over the last 12 months of about $800 million and employs approximately 4,425 people worldwide. Corporate headquarters are located at 8005 S.W. Boeckman Road, Wilsonville, Oregon, 97070-7777. World Wide Web site:http://www.mentor.com/.

-- July 10, 2009 SPSS Inc. (Nasdaq: SPSS | Quote | Chart | News | PowerRating) closed at $31.03 on a volume of 80,139 shares.

In a press release out on July 13, 2009 Predictive Analytics and Statisticians Elevated to Leading Competitive Weapons for Organizations Worldwide

PASW(R) Statistics - Core of SPSS Predictive Analytics Software - Reduces Marketing Costs, Improves Customer Retention, Stops Fraudulent Activity

CHICAGO, Jul 13, 2009 -- Smart and savvy organizations worldwide are harnessing the exponential growth of data with Predictive Analytics to better understand, translate and visualize how customers, constituents or employees will likely behave tomorrow.

Additionally, the growing use of advanced statistical analysis from SPSS Inc. (Nasdaq: SPSS | Quote | Chart | News | PowerRating) - the foundation of Predictive Analytics - has also created leadership opportunities for statisticians, business line managers and analysts who are turning data into actionable insights. Not surprisingly, a recent study of today's best careers released by CareerCast.com (with data based, in part, on the U.S. Bureau of Labor Statistics and the Census Bureau) rated Mathematician first and Statistician third.

About SPSS Inc.

SPSS Inc. is a leading global provider of Predictive Analytics software and solutions. The Company's complete portfolio of Predictive Analytics Software (PASW) products - data collection, statistics, modeling and deployment - captures people's attitudes and opinions, predicts outcomes of future customer interactions, and then acts on these insights by embedding analytics into business processes. SPSS Solutions address interconnected business objectives across an entire organization by focusing on the convergence of analytics, IT architecture and business process. Commercial, government and academic customers worldwide rely on SPSS technology as a competitive advantage in attracting, retaining and growing customers, while reducing fraud and mitigating risk. Founded in 1968, SPSS is headquartered in Chicago, Illinois. For more information, please visit www.spss.com.

-- July 10, 2009 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN | Quote | Chart | News | PowerRating) closed at $14.25 on a volume of 653,118 shares.

In a press release out on July 13, 2009 Patient Enrollment Complete for Phase I/II Clinical Trial for GALNS for Morquio A Syndrome

NOVATO, Calif., July 13, 2009 -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN | Quote | Chart | News | PowerRating) announced today that patient enrollment has been completed for the Phase I/II clinical trial for BMN-110 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for the treatment of the lysosomal storage disorder Mucopolysaccharidosis Type IVA (MPS IVA), or Morquio A Syndrome. The company expects to report initial results in the first half of 2010.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and preclinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product that was developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, a product for the treatment of phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is currently in Phase I clinical development for the treatment of PKU. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

-- July 10, 2009 Magellan Petroleum Corporation (Nasdaq: MPET | Quote | Chart | News | PowerRating) closed at $0.95 on a volume of 95,156 shares

In a press release out on July 13, 2009 Magellan Announces Heads of Agreement and Exclusivity Agreement

PORTLAND, Maine, July 13, 2009 -- Magellan Petroleum Corporation (Nasdaq: MPET | Quote | Chart | News | PowerRating) (ASX: MGN) announced that its wholly owned subsidiary, Magellan Petroleum Australia Limited ("MPAL"), has signed a Heads of Agreement and Exclusivity Agreement with a major methanol producer to study the feasibility of building and operating a methanol plant in the Darwin area, Northern Territory, Australia.

About Magellan

Magellan's common stock is quoted on the NASDAQ Capital Market (symbol: MPET | Quote | Chart | News | PowerRating) and on the Australian Stock Exchange in the form of CDI's (symbol: MGN). The Company is engaged in the sale of energy arising from exploration and development of oil and gas reserves. Currently, MPAL's oil and gas production assets are located in the Amadeus Basin of the Northern Territory in Australia, where MPAL operates the Palm Valley gas field and maintains an interest in the Mereenie oil & gas field as well as the unconnected Dingo gas field. Other reserves and prospects are located elsewhere in Australia and in the United Kingdom.

About PicksThatMove.com

www.picksthatmove.com team of excellence strives to find undervalued, good momentum stock plays. We provide financial and investor relations services for small to mid-cap stocks with weekly and special newsletters to keep you informed of the latest movers. Unlike other sites, we explore, research, and understand all aspects of a company. We only recommend companies we feel has the potential for future higher valuations. Our seasoned research team is always looking for the next Xtreme Pick to send to you.

www.picksthatmove.com is a leading stock website that provides free daily alerts on stocks that are moving up. www.picksthatmove.com also tracks small cap stocks that are on the brink of exploding. We also feature companies on our website with research report, analysis, and newsletters. To feature a company on our web site please contact us at Info@picksthatmove.com

www.picksthatmove.com is an independent electronic publication that provides information on selected publicly traded companies. www.picksthatmove.com is not a registered investment advisor or broker-dealer. www.picksthatmove.com affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.

CONTACT: PicksThatMove.com
e-mail: Info@picksthatmove.com
WWW: http://www.picksthatmove.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on Alphatec Holdings Inc (ATEC) ATEC. Alphatec Holdings Inc (ATEC) has Short Term PowerRatings at TradingMarkets. Details on Alphatec Holdings Inc (ATEC) Short Term PowerRatings is available at This Link.

For full details on Mentor Graphics Corp (MENT) MENT. Mentor Graphics Corp (MENT) has Short Term PowerRatings at TradingMarkets. Details on Mentor Graphics Corp (MENT) Short Term PowerRatings is available at This Link.

For full details on Biomarin Pharmaceuticals (BMRN) BMRN. Biomarin Pharmaceuticals (BMRN) has Short Term PowerRatings at TradingMarkets. Details on Biomarin Pharmaceuticals (BMRN) Short Term PowerRatings is available at This Link.

For full details on Spss Inc (SPSS) SPSS. Spss Inc (SPSS) has Short Term PowerRatings at TradingMarkets. Details on Spss Inc (SPSS) Short Term PowerRatings is available at This Link.

For full details on Magellan Petroleum Corp (MPET) MPET. Magellan Petroleum Corp (MPET) has Short Term PowerRatings at TradingMarkets. Details on Magellan Petroleum Corp (MPET) Short Term PowerRatings is available at This Link.

For full details on Flamel Technologies Sa (FLML) FLML. Flamel Technologies Sa (FLML) has Short Term PowerRatings at TradingMarkets. Details on Flamel Technologies Sa (FLML) Short Term PowerRatings is available at This Link.